MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

October 04, 2017

In 2017, nearly half of MSF's patients in Serbia were under 18; almost all of them were refugees and asylum-seekers who were traveling unaccompanied or became separated from their parents. Minors are supposed to be protected by the system, but many of these young people report violent abuse by European Union border authorities and police.

September 19, 2016

With winter starting to factor into people's thoughts, prospects seem grim for many of the migrants living in the notorious "Jungle" camp in Calais, in northern France. The French government has vowed to shut the camp down once and for all. Another barrier—a 13-foot-high, half-mile-long wall—appears set to go up. And just this week, Calais residents held demonstrations and set up roadblocks demanding that the camp be razed.

Even though assistance to the camp appears to have thinned, people are still making their way there.

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

December 13, 2013

As Syrian refugees increasingly head towards Bulgaria, MSF is working to provide aid and assist the overstretched Bulgarian authorities.

November 22, 2013

Hundreds of refugees are living in appalling conditions in Bulgarian reception centers where there is a disastrous lack of medical care.

October 04, 2017

In 2017, nearly half of MSF's patients in Serbia were under 18; almost all of them were refugees and asylum-seekers who were traveling unaccompanied or became separated from their parents. Minors are supposed to be protected by the system, but many of these young people report violent abuse by European Union border authorities and police.

September 19, 2016

With winter starting to factor into people's thoughts, prospects seem grim for many of the migrants living in the notorious "Jungle" camp in Calais, in northern France. The French government has vowed to shut the camp down once and for all. Another barrier—a 13-foot-high, half-mile-long wall—appears set to go up. And just this week, Calais residents held demonstrations and set up roadblocks demanding that the camp be razed.

Even though assistance to the camp appears to have thinned, people are still making their way there.

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

December 13, 2013

As Syrian refugees increasingly head towards Bulgaria, MSF is working to provide aid and assist the overstretched Bulgarian authorities.

November 22, 2013

Hundreds of refugees are living in appalling conditions in Bulgarian reception centers where there is a disastrous lack of medical care.